COVID Vaccines: US FDA Seeks Panel Vote On New Formulation Targeting JN.1 Variant

 
• By Sue Sutter
  
Global
Recent epidemiology in the US could complicate the global drive for alignment on COVID-19 vaccine formulations. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers